(Q33314992)

25 July 2017

title

The use of progesterone for prevention of preterm birth (English)

1 reference

25 July 2017

Jodie Dodd

3

0 references

author name string

Dan Farine

1

1 reference

25 July 2017

William Robert Mundle

2

1 reference

25 July 2017

Melanie Basso

4

1 reference

25 July 2017

Marie-France Delisle

5

1 reference

25 July 2017

Dan Farine

6

1 reference

25 July 2017

Kirsten Grabowska

7

1 reference

25 July 2017

Lynda Hudon

8

1 reference

25 July 2017

Savas Michael Menticoglou

9

1 reference

25 July 2017

Lynn Carole Murphy-Kaulbeck

10

1 reference

25 July 2017

Annie Ouellet

11

1 reference

25 July 2017

Tracy Pressey

12

1 reference

25 July 2017

Anne Roggensack

13

1 reference

25 July 2017

Robert Gagnon

14

1 reference

25 July 2017

Maternal Fetal Medicine Committee of the Society of Obstetricians and Gynaecologists of Canada

15

1 reference

25 July 2017

publication date

1 January 2008

1 reference

Journal of Obstetrics and Gynaecology Canada

25 July 2017

published in

1 reference

25 July 2017

volume

30

1 reference

25 July 2017

issue

1

1 reference

25 July 2017

page(s)

67-77

1 reference

Determinants of preterm birth rates in Canada from 1981 through 1983 and from 1992 through 1994.

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932716-5

7 January 2021

Randomized double-blind placebo-controlled trial of transdermal nitroglycerin for preterm labor

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932716-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932716-5

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932716-5

1 reference

7 January 2021

Progesterone for the prevention of preterm birth among women at increased risk: a systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932716-5

7 January 2021

Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932716-5

7 January 2021

Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932716-5

7 January 2021

Efficacy of 17α-Hydroxyprogesterone Caproate in the Prevention of Premature Labor

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932716-5

7 January 2021

The effect of 17α-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932716-5

7 January 2021

Prevention of premature labor by 17α-hydroxyprogesterone caproate

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932716-5

7 January 2021

Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932716-5

7 January 2021

Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932716-5

7 January 2021

Progesterone and the risk of preterm birth among women with a short cervix

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932716-5

7 January 2021

A Trial of 17 Alpha-Hydroxyprogesterone Caproate to Prevent Prematurity in Twins

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932716-5

7 January 2021

Progestogen administration in pregnancy may prevent preterm delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932716-5

7 January 2021

A meta-analysis of randomized control trials of progestational agents in pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932716-5

7 January 2021

Cervical length changes during preterm cervical ripening: effects of 17-α-hydroxyprogesterone caproate

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932716-5

7 January 2021

The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932716-5

7 January 2021

Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932716-5

7 January 2021

Impact of the recent randomized trials on the use of progesterone to prevent preterm birth: A 2005 follow-up survey

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932716-5

7 January 2021

Preterm labour and birth: a survey of clinical practice regarding use of tocolytics, antenatal corticosteroids, and progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932716-5

7 January 2021

Increased Incidence of Gestational Diabetes in Women Receiving Prophylactic 17 -Hydroxyprogesterone Caproate for Prevention of Recurrent Preterm Delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932716-5

7 January 2021

Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter?

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932716-5

7 January 2021

10.1016/S1701-2163(16)32716-5

Identifiers

DOI

0 references

1 reference